Matthew A. Cooper
Has participated in:
-
Characterisation of small molecule ligands 4CMTB and 2CTAP as modulators of human FFA2 receptor signalling
-
Interleukin-10 regulates the inflammasome-driven augmentation of inflammatory arthritis and joint destruction
-
Light‐Activated Rhenium Complexes with Dual Mode of Action against Bacteria
-
Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals